Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Secale cereale
A purified rye pollen extract clinically proven for benign prostatic hyperplasia (BPH) and prostatitis; contains phytosterols and polyunsaturated fatty acids that reduce prostate size.
Pollen extract from Secale cereale (rye) is a clinically studied phytotherapeutic agent primarily used for benign prostatic hyperplasia (BPH) and prostatitis. It contains phytosterols, polyunsaturated fatty acids, and polysaccharides that contribute to its anti-inflammatory and anti-androgenic properties. Standardized extracts such as Cernitin are supported by limited clinical evidence for improving urinary symptoms and reducing prostate size.
The extract inhibits 5-alpha-reductase and aromatase enzymes, reducing conversion of testosterone to dihydrotestosterone (DHT) and androgens to estrogens, thereby decreasing prostate cell proliferation. It also exerts anti-inflammatory effects by inhibiting cyclooxygenase (COX) and lipoxygenase pathways, reducing prostaglandin and leukotriene synthesis. Additionally, the phytosterols may block alpha-adrenergic receptors, relaxing smooth muscle in the prostate and bladder neck, improving urinary flow.
A purified rye pollen extract clinically proven for benign prostatic hyperplasia (BPH) and prostatitis; contains phytosterols and polyunsaturated fatty acids that reduce prostate size.
Pollen extract from Secale cereale (rye) is a clinically studied phytotherapeutic agent primarily used for benign prostatic hyperplasia (BPH) and prostatitis. It contains phytosterols, polyunsaturated fatty acids, and polysaccharides that contribute to its anti-inflammatory and anti-androgenic properties. Standardized extracts such as Cernitin are supported by limited clinical evidence for improving urinary symptoms and reducing prostate size.
The extract inhibits 5-alpha-reductase and aromatase enzymes, reducing conversion of testosterone to dihydrotestosterone (DHT) and androgens to estrogens, thereby decreasing prostate cell proliferation. It also exerts anti-inflammatory effects by inhibiting cyclooxygenase (COX) and lipoxygenase pathways, reducing prostaglandin and leukotriene synthesis. Additionally, the phytosterols may block alpha-adrenergic receptors, relaxing smooth muscle in the prostate and bladder neck, improving urinary flow.